Muutke küpsiste eelistusi

Strategies of Cancer Prevention in Gastroenterology 2009 ed. [Kõva köide]

Edited by , Edited by , Edited by , Edited by
  • Formaat: Hardback, 116 pages, kõrgus x laius: 235x155 mm, kaal: 367 g, XI, 116 p., 1 Hardback
  • Sari: Falk Symposium 165A
  • Ilmumisaeg: 25-May-2009
  • Kirjastus: Springer
  • ISBN-10: 9048126282
  • ISBN-13: 9789048126286
Teised raamatud teemal:
  • Kõva köide
  • Hind: 187,67 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 220,79 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 116 pages, kõrgus x laius: 235x155 mm, kaal: 367 g, XI, 116 p., 1 Hardback
  • Sari: Falk Symposium 165A
  • Ilmumisaeg: 25-May-2009
  • Kirjastus: Springer
  • ISBN-10: 9048126282
  • ISBN-13: 9789048126286
Teised raamatud teemal:
This book is the proceedings of the Falk Workshop on ‘Strategies of Cancer Prevention in Gastroenterology', held in Mainz, Germany, on 17 September 2008. The meeting was a unique opportunity to assemble so many of the world's best experts to discuss the state of the art and future developments and challenges in cancer prevention in gastroenterology. Barrett's, gastric and colorectal cancer were the main topics, with cancer in inflammatory bowel disease as a particular subject. The overall impression of the meeting was the experience that in many countries of the world the strategies are similar with, of course, focus on different ways to reach the same goal of reducing incidence and cancer mortality. It was extremely stimulating to exchange new ideas and new concepts and to see what progress in public awareness has been made in different countries. Cancer prevention is and will continue to remain a major political as well as a genuinely medical task, to work for more convenient and useful programs and to carry the burden of broad acceptance. This workshop was another milestone on the long road towards this difficult goal. All those working in this important field will find in this book detailed information and instruction for their clinical and/or scientific activities.
List of principal contributors
vii
List of chairpersons
ix
Preface xi
SESSION I: BARRETT'S CANCER
C Ell
SJ Spechler
Epidemiology of cancer in Barrett's oesophagus
3(8)
SJ Spechler
Barrett's cancer - correlation to reflux disease
11(7)
M Lindblad
Existing guidelines
18(6)
H Koop
Barrett's cancer - strategies for surveillance
24(9)
O Pech
SESSION II: GASTRIC CANCER
PR Galle
P Malfertheiner
Worldwide trends in gastric cancer epidemiology
33(10)
H Brenner
An innovative concept of tumour initiation based on Helicobacter-driven gastric carcinogenesis
43(8)
H Li
C Stoicov
X Fan
J Houghton
How to prevent gastric cancer in East and West
51(14)
K Sugano
SESSION III: COLORECTAL CANCER
D Lieberman
JF Riemann
Frequency of colorectal cancer and new screening guidelines
65(4)
D Lieberman
Who has an increased risk for colorectal cancer
69(5)
K Schulmann
Chemoprevention for colorectal cancer
74(8)
RW Burt
Colon carcinoma - the role of public awareness
82(5)
JF Riemann
SESSION IV: CANCER IN INFLAMMATORY BOWEL DISEASE
MF Neurath
M Zeitz
Cancer in inflammatory bowel disease: frequency and clinical presentation
87(5)
H Tilg
Patients at risk for colorectal cancer in inflammatory bowel disease
92(5)
CN Bernstein
Cancer in inflammatory bowel disease: is there a chance for cancer prevention?
97(10)
C Gasche
C Campregher
G Luciani
Index 107